The use of multivitamin/multimineral supplements: A modified Delphi consensus panel report

dc.contributor.authorBlumberg, Jeffrey B.
dc.contributor.authorCena, Hellas
dc.contributor.authorBarr, Susan Irene
dc.contributor.authorBiesalski, Hans Konrad
dc.contributor.authorDagach, Ricardo Uauy
dc.contributor.authorDelaney, Brendan C.
dc.contributor.authorFrei, Balz B.
dc.contributor.authorMoreno González, Manuel Ignacio
dc.contributor.authorHwalla, Nahla C.
dc.contributor.authorLategan-Potgieter, Ronette
dc.contributor.authorMcNulty, Helene M.
dc.contributor.authorvan der Pols, Jolieke C.
dc.contributor.authorWinichagoon, Pattanee
dc.contributor.authorLi, Duo
dc.contributor.departmentDepartment of Nutrition and Food Sciences
dc.contributor.facultyFaculty of Agricultural and Food Sciences (FAFS)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:19:01Z
dc.date.available2025-01-24T11:19:01Z
dc.date.issued2018
dc.description.abstractPurpose: Evidence supporting the use of dietary supplements, in particular, multivitamin/multimineral supplements (MVMS), has been mixed, complicating the ability of health care professionals to recommend their use. To clarify the role that MVMS can play in supporting human health, a series of consensus statements was developed based on expert opinion. Methods: A panel of 14 international experts in nutritional science and health care was convened to develop consensus statements related to using MVMS in supporting optimal human health. The modified Delphi process included 2 rounds of remote voting and a final round of voting at a roundtable meeting where evidence summaries were presented and discussed. The level of agreement with each of 9 statements was rated on a 5-point Likert scale: agree strongly; agree with reservation; undecided; disagree; or disagree strongly. Consensus was predefined as ≥80% of the panel agreeing strongly or agreeing with reservation to a given statement. Findings: Consensus was reached for all statements. The panel determined that MVMS can broadly improve micronutrient intakes when they contain at least the micronutrients that are consumed insufficiently or have limited bioavailability within a specified population. MVMS formulations may also be individualized according to age, sex, life cycle, and/or other selected characteristics. There are specific biological processes and health outcomes associated with deficient, inadequate, and adequate micronutrient levels. Adequate intake is necessary for normal biological functioning required for good health; in some instances, higher than recommended micronutrient intakes have the potential to provide additional health benefits. Meeting daily intakes established by dietary reference values should be an explicit public health goal for individuals and populations. Use of MVMS is one approach to ensure that adequate micronutrient needs are met in support of biological functions necessary to maintain health. Long-term use of MVMS not exceeding the upper limit of recommended intakes has been determined to be safe in healthy adults. There is insufficient evidence to indicate that MVMS are effective for the primary prevention of chronic medical conditions, including cardiovascular disease and cancer. However, for certain otherwise healthy subpopulations (eg, pregnant women, older adults) and some individuals with existing medical conditions who experience inadequacies in micronutrient intake, addressing inadequacies by using MVMS can provide health benefits. Implications: This consensus panel has described key issues related to the use of MVMS among individuals at risk of or presenting with inadequacies in micronutrient intake or biomarker status. © 2018 The Authors
dc.identifier.doihttps://doi.org/10.1016/j.clinthera.2018.02.014
dc.identifier.eid2-s2.0-85044306822
dc.identifier.pmid29573851
dc.identifier.urihttp://hdl.handle.net/10938/24780
dc.language.isoen
dc.publisherExcerpta Medica Inc.
dc.relation.ispartofClinical Therapeutics
dc.sourceScopus
dc.subjectAdverse effects
dc.subjectDelphi consensus
dc.subjectDietary supplements
dc.subjectHealth benefits
dc.subjectMultivitamin/multimineral supplements
dc.subjectNutrition
dc.subjectAged
dc.subjectBiological availability
dc.subjectChronic disease
dc.subjectConsensus
dc.subjectDiet
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectNutritional status
dc.subjectPregnancy
dc.subjectVitamins
dc.subjectMineral
dc.subjectMultimineral
dc.subjectMultivitamin
dc.subjectUnclassified drug
dc.subjectVitamin
dc.subjectAdult
dc.subjectAge
dc.subjectBreast feeding
dc.subjectChild
dc.subjectDiet supplementation
dc.subjectDietary supplement
dc.subjectEye disease
dc.subjectHealth care
dc.subjectHuman
dc.subjectNon insulin dependent diabetes mellitus
dc.subjectNormal human
dc.subjectNutritional science
dc.subjectObesity
dc.subjectPregnant woman
dc.subjectReview
dc.subjectWomen's health
dc.subjectBioavailability
dc.subjectNutrition
dc.titleThe use of multivitamin/multimineral supplements: A modified Delphi consensus panel report
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2018-8291.pdf
Size:
501.03 KB
Format:
Adobe Portable Document Format